Summary
The precise phenotype and clinical course are described of a subgroup of acute nonlymphoblastic leukemias (ANLL) expressing the NK-cell differentiation antigen CD56. As previously reported, CD56+ leukemias occurred in a frequency of about 20% of ANLL cases showing clinical and immunophenotypical heterogeneity. Carrying various myelomonocytic markers, all cases were diagnosed to be of nonlymphoid origin. Positive or negative expression of CD34 allowed us to distinguish two major subtypes of CD56+ leukemias representing immature and more differentiated cells carrying further differentiation antigens (CD14 and/or CD15) of the myelomonocytic lineages. These phenotypes correlated with the M0, M2, M4, and M5 leukemias of the FAB classification.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1991) Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO). Br J Haematol 78: 325–329
Catovsky D, Matutes E, Buccheri V, Shetty V, Hanslip J, Yoshida N, Morilla R (1991) A classification of acute leukaemia for the 1990s. Ann Hematol 62: 16–21
Gadd S (1989) Cluster report: CD14. In: Knapp W (ed) Leukocyte typing IV. Oxford University Press, Oxford, pp 787–798
Griffin JD, Hercend T, Beveridge R, Schlossman SF (1983) Characterization of an antigen expressed by human natural killer cells. J Immunol 130: 2947–2951
Hercend T, Griffin JD, Bensussan A, Schmidt RE, Edson MA, Brennan A, Murray C, Daley JF, Schlossman SF, Ritz J (1985) Generation of monoclonal antibodies to a human natural killer clone. J Clin Invest 75: 932–943
Knapp W (1989) International workshop and conference on human leukocyte differentiation antigens. Oxford University Press, Oxford
Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH (1986) The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T-lymphocytes. J Immunol 136: 4480–4486
Lanier LL, Le AM, Ding A, Evans EL, Krensky AM, Clayberger C, Phillips JH (1987) Expression of Leu-19 (NKH-1) antigen on IL 2-dependent cytotoxic and non-cytotoxic T cell lines. J Immunol 138: 2019–2023
Lanier LL, Testi R, Bindl J, Phillips JH (1989) Identitiy of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med 169: 2233–2238
Müller C, Ziegler A, Muller C, Hadam M, Waller HD, Wernet P, Müller G (1985) Divergent expression of HLA-DC/MB, -DR, and -SB region products on normal and pathological tissues as detected by monoclonal antibodies. Immunobiology 169: 228–249
Müller GA, Müller C, Risler T (1984) Charakterisierung glomerulärer Halbmonde bei rapid progressiver Glomerulonephritis (RPGN) mit Hilfe monoklonaler Antikörper. Verh Dtsch Ges Inn Med 90: 1013–1016
Norton JD, Campana D, Hoffbrand AV, Janossy G, Coustan-Smith E, Jani H, Yaxley JC, Prentice HG (1988) Rearrangement of immunoglobulin and T-cell antigen receptor genes in acute myeloid leukemia with lymphoid-associated markers. Leukemia 1: 757–761
Tauchi T, Ohyashiki K, Ohyashiki JH, Kawanishi Y, Kimura Y, Saito M, Nakazawa S, Kawai Y, Toyama K (1990) CD 4+ and CD 56+ acute monoblastic leukemia. Am J Hematol 34: 228
Willman CL, Stewart CC, Elias L, Potter J, Kopecky K, Stock-Novak D, Head D, Weick JK, Grever MR (1988) Identification of new biological subtypes of acute leukemia co-expressing NK (LEU19) and myeloid cell surface antigens: a Southwest Oncology Group (SWOG) study. Blood 77 [Suppl 1]: 236 (abstract)
Ziegler A, Heinig J, Müller C, Gitz H, Thinnes FP, Uchanska-Ziegler B, Wernet P (1986) Analysis by sequential immunoprecipitations of the monoclonal antibodies Tü22, 34, 36, 37, 39, 43, 58 and YD 1/63. HLK directed against human HLA class-II-antigens. Immunobiology 171: 77–92
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Reuss-Borst, M.A., Steinke, B., Waller, H.D. et al. Phenotypic and clinical heterogeneity of CD56-positive acute nonlymphoblastic leukemia. Ann Hematol 64, 78–82 (1992). https://doi.org/10.1007/BF01715349
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01715349